Medibio Limited
TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Med… Read more
Medibio Limited (MDBIF) - Total Assets
Latest total assets as of June 2025: $13.48 Million USD
Based on the latest financial reports, Medibio Limited (MDBIF) holds total assets worth $13.48 Million USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Medibio Limited - Total Assets Trend (2001–2025)
This chart illustrates how Medibio Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Medibio Limited - Asset Composition Analysis
Current Asset Composition (June 2025)
Medibio Limited's total assets of $13.48 Million consist of 9.6% current assets and 90.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 9.3% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $9.33 Million | 69.2% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2001–2025)
This chart illustrates how Medibio Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Medibio Limited's current assets represent 9.6% of total assets in 2025, a decrease from 26.5% in 2001.
- Cash Position: Cash and equivalents constituted 9.3% of total assets in 2025, down from 23.5% in 2001.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 69.0% of total assets, a decrease from 70.0% in 2001.
- Asset Diversification: The largest asset category is intangible assets at 69.2% of total assets.
Medibio Limited Competitors by Total Assets
Key competitors of Medibio Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
UCrest Bhd
KLSE:0005
|
Malaysia | RM48.46 Million |
|
Vanfund Urban Investment & Development Co Ltd
SHE:000638
|
China | CN¥265.74 Million |
|
BIT Computer Co. Ltd
KQ:032850
|
Korea | ₩82.38 Billion |
|
ezCaretech Co. LTD
KQ:099750
|
Korea | ₩56.71 Billion |
|
SyntekaBio Inc
KQ:226330
|
Korea | ₩33.49 Billion |
|
Carelabs Co.Ltd
KQ:263700
|
Korea | ₩105.15 Billion |
|
Shanghai Kingstar Winning Software
SHE:300253
|
China | CN¥8.35 Billion |
|
Longmaster Information Tech
SHE:300288
|
China | CN¥1.33 Billion |
Medibio Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Medibio Limited generates 0.08x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Medibio Limited is currently not profitable relative to its asset base.
Medibio Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.86 | 0.78 | 0.61 |
| Quick Ratio | 1.86 | 0.78 | 0.61 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $599.92K | $ -258.76K | $ -542.49K |
Medibio Limited - Advanced Valuation Insights
This section examines the relationship between Medibio Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.32 |
| Latest Market Cap to Assets Ratio | 0.08 |
| Asset Growth Rate (YoY) | 21.8% |
| Total Assets | $13.48 Million |
| Market Capitalization | $1.02 Million USD |
Valuation Analysis
Below Book Valuation: The market values Medibio Limited's assets below their book value (0.08 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Medibio Limited's assets grew by 21.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Medibio Limited (2001–2025)
The table below shows the annual total assets of Medibio Limited from 2001 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | $13.48 Million | +21.83% |
| 2024-06-30 | $11.07 Million | +37.77% |
| 2023-06-30 | $8.03 Million | -5.36% |
| 2022-06-30 | $8.49 Million | -51.16% |
| 2021-06-30 | $17.38 Million | +24.02% |
| 2020-06-30 | $14.01 Million | +5.34% |
| 2019-06-30 | $13.30 Million | -30.22% |
| 2018-06-30 | $19.06 Million | -0.97% |
| 2017-06-30 | $19.25 Million | +7.42% |
| 2016-06-30 | $17.92 Million | +18.02% |
| 2015-06-30 | $15.18 Million | +201.13% |
| 2014-06-30 | $5.04 Million | -6.95% |
| 2013-06-30 | $5.42 Million | -1.05% |
| 2012-06-30 | $5.48 Million | +67.12% |
| 2011-06-30 | $3.28 Million | +132.63% |
| 2010-06-30 | $1.41 Million | -48.28% |
| 2009-06-30 | $2.72 Million | -55.88% |
| 2008-06-30 | $6.17 Million | +199.41% |
| 2007-06-30 | $2.06 Million | -15.59% |
| 2006-06-30 | $2.44 Million | -47.77% |
| 2005-06-30 | $4.68 Million | -8.93% |
| 2004-06-30 | $5.13 Million | -5.58% |
| 2003-06-30 | $5.44 Million | -21.91% |
| 2002-06-30 | $6.96 Million | -0.51% |
| 2001-06-30 | $7.00 Million | -- |